| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5902668 | Journal of Diabetes and its Complications | 2014 | 7 Pages |
Abstract
Lixisenatide plus basal insulin resulted in significant improvement in glycemic control versus basal insulin alone, particularly in terms of controlling PPG. Prandial lixisenatide in combination with basal insulin is a suitable option for treatment intensification in patients with T2DM insufficiently controlled with basal insulin, as these agents have complementary effects on PPG and FPG, respectively.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Bernard Charbonnel, Monica Bertolini, Francisco J. Tinahones, Manuel Puig Domingo, Melanie Davies,